Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Curr Top Med Chem ; 20(9): 759-769, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32108009

RESUMO

Mood disorders and Major Depressive Disorder, in particular, appear to be some of the most common psychiatric disorders with a high rate of comorbidity most frequently of anxiety or substance abuse disorders (alcohol use disorder). In both cases - MDD and AUD, a number of immunological disturbances are observed, such as chronic mild inflammation response, increased level of cytokines, hypercortisolaemia, which lead to specific changes in brain neurotransmitter functions. Some of the contemporary brain imaging techniques are functional magnetic resonance imaging (fMRI) and magnetic spectroscopy which are most commonly used to assess the brain metabolism and functional connectivity changes such as altered responses to emotional stimuli in MDD or overactivation of ventromedial prefrontal areas during delayed and underactivation of dorsolateral prefrontal regions during impulsive reward decisions in AUD and dysfunction of gamma-aminobutyric acid (GABA) and/or glutamate neurotransmitter systems, low NAA and myo-Inositol in both MDD and AUD.


Assuntos
Alcoolismo/patologia , Transtornos de Ansiedade/patologia , Transtorno Depressivo Maior/patologia , Imageamento por Ressonância Magnética/métodos , Neuroimagem/métodos , Encéfalo/patologia , Comorbidade , Citocinas/metabolismo , Ácido Glutâmico/metabolismo , Humanos , Inositol/metabolismo , Testes Neuropsicológicos , Neurotransmissores/imunologia , Índice de Gravidade de Doença , Ácido gama-Aminobutírico/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...